Inhibition of nuclear factor kappaB by sulfasalazine: a new target for inflammatory bowel disease therapy?

Article Details

Citation
Copy to clipboard

Egan LJ, Sandborn WJ

Inhibition of nuclear factor kappaB by sulfasalazine: a new target for inflammatory bowel disease therapy?

Gastroenterology. 1998 Nov;115(5):1295-6.

PubMed ID
9797390 [ View in PubMed
]
Abstract

Not Available

DrugBank Data that Cites this Article

Drug Targets
DrugTargetKindOrganismPharmacological ActionActions
OlsalazineInterferon gammaProteinHumans
Yes
Not AvailableDetails